Global Pharmatech(GBLP)
$0.080.00 (0.00%)
GBLP
Global Pharmatech financials statements
$0.08
At close:0.00 (0.00%)
Global Pharmatech (GBLP) Ratios
6 Followers
Global Pharmatech Ratios
GBLP's free cash flow for Q1 2026 was $-79.94K. For the 2026 fiscal year, GBLP's free cash flow was increased by $0.00 and operating cash flow was $-79.94K. See a summary of the company’s cash flow.
| Ratios | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|
| Liquidity Ratios | ||||
| Current Ratio | 0.44 | 0.32 | 0.31 | 0.03 |
| Quick Ratio | 0.41 | 0.27 | 0.27 | 0.03 |
| Cash Ratio | 0.03 | 0.03 | 0.05 | 0.00 |
| Solvency Ratio | -0.07 | 0.05 | 0.33 | 2.43 |
| Operating Cash Flow Ratio | 0.02 | -0.33 | 0.63 | -1.24 |
| Short-Term Operating Cash Flow Coverage | 0.19 | 0.00 | 7.83 | 0.00 |
| Net Current Asset Value | $ -485.67K | $ -411.53K | $ -430.02K | $ -49.26K |
| Leverage Ratios | ||||
| Debt-to-Assets Ratio | 0.11 | 0.00 | 0.12 | 0.00 |
| Debt-to-Equity Ratio | -0.67 | 0.00 | -0.25 | 0.00 |
| Debt-to-Capital Ratio | -2.01 | 0.00 | -0.34 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -6.25 | -2.02 | -2.18 | -0.03 |
| Debt Service Coverage Ratio | -0.74 | 80.93 | 4.14 | -3236.57 |
| Interest Coverage Ratio | -113.24 | -379.56 | -188.73 | -3236.57 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | -0.85 | -0.71 | 0.08 | 0.00 |
| Profitability Margins | ||||
| Gross Profit Margin | 11.15% | 66.02% | 50.18% | 0.00% |
| EBIT Margin | -21.59% | -208.11% | -35.66% | 0.00% |
| EBITDA Margin | -19.27% | 44.84% | 354.35% | 0.00% |
| Operating Profit Margin | -21.81% | -210.28% | -37.21% | 0.00% |
| Pretax Profit Margin | -21.78% | -208.66% | -35.85% | 0.00% |
| Net Profit Margin | -21.78% | -208.66% | -35.85% | 0.00% |
| Continuous Operations Profit Margin | -21.78% | -208.66% | -35.85% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 99.87% | 99.23% | 96.35% | 100.03% |
| Return on Assets (ROA) | -9.01% | -34.09% | -4.91% | -8025.07% |
| Return on Equity (ROE) | 56.28% | 69.03% | 10.69% | 230.01% |
| Return on Capital Employed (ROCE) | 56.36% | 69.56% | 11.10% | 229.94% |
| Return on Invested Capital (ROIC) | 169.86% | 69.56% | 14.89% | 229.94% |
| Return on Tangible Assets | -9.01% | -34.09% | -6.43% | -8025.07% |
| Earnings Yield | -0.11% | -0.15% | -0.04% | -0.16% |
| Efficiency Ratios | ||||
| Receivables Turnover | 0.95 | 0.47 | 0.43 | 0.00 |
| Payables Turnover | 0.64 | 0.00 | 0.12 | 0.00 |
| Inventory Turnover | 9.90 | 0.74 | 1.25 | 0.00 |
| Fixed Asset Turnover | 3.70 | 0.63 | 0.46 | 0.00 |
| Asset Turnover | 0.41 | 0.16 | 0.14 | 0.00 |
| Working Capital Turnover Ratio | -0.69 | -0.16 | -0.24 | 0.00 |
| Cash Conversion Cycle | -145.47 | 1274.90 | -1810.79 | 0.00 |
| Days of Sales Outstanding | 385.43 | 779.88 | 852.13 | 0.00 |
| Days of Inventory Outstanding | 36.87 | 495.03 | 292.17 | 0.00 |
| Days of Payables Outstanding | 567.76 | 0.00 | 2955.09 | 0.00 |
| Operating Cycle | 422.30 | 1274.90 | 1144.30 | 0.00 |
| Cash Flow Ratios | ||||
| Operating Cash Flow Per Share | 0.00 | -0.00 | 0.00 | -0.00 |
| Free Cash Flow Per Share | 0.00 | 0.00 | 0.00 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | 1.00 | -1.00 | 1.71 | 0.00 |
| Capital Expenditure Coverage Ratio | 1.00 | -1.00 | 1.71 | 0.00 |
| Operating Cash Flow Coverage Ratio | 0.19 | 0.00 | 7.83 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.05 | -3.00 | 6.68 | 0.00 |
| Free Cash Flow Yield | 0.00% | 0.00% | 0.29% | -0.09% |
| Valuation Ratios | ||||
| Price-to-Earnings (P/E) Ratio | -762.50 | -684.85 | -2693.31 | -634.09 |
| Price-to-Sales (P/S) Ratio | 198.76 | 1429.01 | 965.61 | 0.00 |
| Price-to-Book (P/B) Ratio | -513.53 | -472.74 | -287.96 | -1458.50 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 0.00 | 0.00 | 347.33 | -1147.09 |
| Price-to-Operating Cash Flow Ratio | 4145.35 | -476.00 | 144.52 | -1147.09 |
| Price-to-Earnings Growth (PEG) Ratio | 15.25 | -2.28 | 35.91 | 0.00 |
| Enterprise Value Multiple | -1032.25 | 3186.48 | 272.59 | -634.28 |
| Enterprise Value | 61.85M | 94.83M | 56.59M | 71.85M |
| EV to EBITDA | -1032.25 | 3186.48 | 272.59 | -634.28 |
| EV to Sales | 198.93 | 1428.69 | 965.90 | 0.00 |
| EV to Free Cash Flow | 0.00 | 0.00 | 347.44 | -1147.09 |
| EV to Operating Cash Flow | 4148.75 | -475.89 | 144.56 | -1147.09 |
| Tangible Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.00 |
| Shareholders’ Equity Per Share | -0.00 | -0.00 | -0.00 | -0.00 |
| Tax and Other Ratios | ||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.00 | -0.00 | -0.00 | -0.00 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.01 | 1.00 | 1.01 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.33 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.22 | 1.44 | -18.64 | 0.55 |
Currency in USD

